| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |